Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
15 Apr 2026
England Relaunches Women’s Health Strategy Amid “Medical Misogyny”
The UK Government has relaunched the Women’s Health Strategy for England on 14th April 2026, following select committee findings of “medical misogyny” in the NHS.
15 Apr 2026
Tuberculosis Vaccine Trial Shows Limited Overall Protection
A phase 3 trial of two tuberculosis vaccines shows limited overall protection but meaningful efficacy against extrapulmonary disease in selected groups.
Dr Henar Hevia talks to data, decision-making and cancer care
Columnist Dr Henar Hevia, J&J Innovative Medicine, explores how oncology’s future hinges on smarter use of data.
15 Apr 2026
England’s Advances Towards Hepatitis C Elimination Targets
England reports progress towards hepatitis C elimination as prevalence falls, with diagnosis gaps and harm reduction challenges remaining.
15 Apr 2026
High-Resolution MRI Improves Brain Imaging Clarity
5.0 T SWI improves brain imaging clarity compared with 3.0 T, enhancing visualisation of cerebral veins and deep grey matter structures in healthy adults.
15 Apr 2026
Entering a New Era in Protection in Haemophilia A
Haemophilia A (HA), defined by factor VIII (FVIII) levels ≤40 IU/dL, is a chronic condition with consequences beyond bleeding…
14 Apr 2026
Poor Diet Drives Global Ischaemic Heart Disease Burden
New findings from the Global Burden of Disease 2023 analysis showed that dietary risks were responsible for an estimated 4.06 million IHD deaths and 96.84 million disability-adjusted life years in 2023.
14 Apr 2026
Music Matches Benzodiazepines in Reducing Perioperative Anxiety
Researchers have calculated the number needed to treat for music intervention in perioperative anxiety and the result is somewhat comparable to that of benzodiazepines.
14 Apr 2026
Low Socioeconomic Status Tied to Lower Rates of Diabetes in China
Low socioeconomic status is, overall, tied to a higher prevalence of hypertension and obesity, but lower odds of diabetes and dyslipidaemia in China.
Novo partners with OpenAI to boost drug development
Novo Nordisk announced on 14 April 2026 a strategic partnership with OpenAI to boost drug development by streamlining manufacturing, supply chains and distribution.
←
1
2
3
…
5
6
7
8
9
10
11
…
1,438
1,439
1,440
→
We’ve noticed you’re accessing
from
North/South America.
View
View